LRRK2 and Parkinson disease: Second, given the alteration in LRRK2 expression and GCase activity in iPD cases, it is possible that altered enzymatic activity of these PD-related proteins in immune cells may serve as potential biomarkers for PD, underscoring the importance of having a robust and reliable assay to measure these activities in human immune cells.